Marked elevation of soluble Fas ligand cytokine after splenectomy in aggressive natural killer cell leukemia/lymphoma

Leukemia and Lymphoma

Volumn 45, Issue 11, 2004, Pages 2291-2294

  Kaizu, Kiyohiko ^a   Maeda, Miho ^a   Ohkawa, Takuya ^a   Hayashida, Mari ^a   Nakajima, Seiko ^b   Sugisaki, Yuichi ^a   Fukunaga, Yoshitaka ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Ageo Central General Hospital   (Japan)

Author keywords

Apoptosis; Cytokine; Hemophagocytosis; Natural killer cell leukemia lymphoma; Soluble Fas ligand

Indexed keywords

ALKYLATING AGENT; CYCLOSPORIN A; CYTOKINE; ETOPOSIDE; FAS LIGAND; FERRITIN; GAMMA INTERFERON; INTERLEUKIN 10; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TRIACYLGLYCEROL;

ADOLESCENT; APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD SMEAR; CASE REPORT; CELL COUNT; CYTOKINE RELEASE; DISEASE COURSE; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FERRITIN BLOOD LEVEL; HUMAN; LEUKEMIA; LIVER CELL; LIVER INJURY; LYMPHOMA; MALE; NATURAL KILLER CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; APOPTOSIS; CYTOKINES; FAS LIGAND PROTEIN; FATAL OUTCOME; FERRITINS; HEPATOCYTES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; KILLER CELLS, NATURAL; LEUKEMIA; LIVER; LYMPHOMA; MALE; MEMBRANE GLYCOPROTEINS; PHAGOCYTOSIS; SPLENECTOMY; TIME FACTORS; TRIGLYCERIDES;

EID: 8644230943     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331283233     Document Type: Article

References (19)

1. Ohnuma, K., Toyoda, Y., Nishihira, H., Iguchi, A., Honda, K., Nagao, T., et al. (1997) "Aggressive natural killer (NK) cell lymphoma: Report of a pediatric case and review of the literature", Leukemia and Lymphoma, 25, 387-392.
2. Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yimura, K., Hara, J., Oda, K., et al. (1990) "Aggressive natural killer cell leukemia/ lymphoma: report of four cases and review of the literature", British Journal of Haematology, 75, 49-59.
3. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., et al. (1996) "Fas ligand in human serum", Nature Medicine, 2, 317-322.
4. Kato, K., Ohshima, K., Anzai, K., Anzai, K., Suzumiya, J. and Kikuchi, M. (2001) "Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis", International Journal of Hematology, 73, 84-86.
5. Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa, A., Kosaka, Y., Nakamura, H., et al. (1998) "Elevation of serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia", Blood, 91, 2793-2799.
6. Kimura, H., Hoshino, Y., Kanegane, H., Tsuge, I., Okamura, T., Kawa, K., et al. (2001) "Clinical and virologic characteristics of chronic active Epstein-Barr virus infection", Blood, 98, 280-286.
7. Aimi, S., Yasoshima, S., Sugai, M., Sato, B., Sakai, T. and Nakajima, Y. (1952) "Studies on the weight and size of internal organ of normal Japanese", Acta Path. Jap., 2, 173-200.
8. Kato, K., Ohshima, K., Ishihara, S., Anzai, K., Suzumiya, J. and Kikuchi, M. (1998) "Elevated serum soluble Fas ligand in natural killer cell proliferative disorders", British Journal of Haematology 103, 1164-1166,
9. Yamamoto, T., Iwasaki, T. and Watanabe, N. (1993) "Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders", Blood, 81, 1342-1346.
10. Manabe, A., Takahashi, K., Shibata, R., Takeuchi, M., Morita, M. and Hosoya, R. (2000) "Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia", Medical and Pediatric Oncology, 34, 224-225.
11. Imashuku, S., Obayashi, M., Hosoi, G., Sako, M., Chen, J., Mugishima, H., et al. (2000) "Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19 + B-cell depletion and therapeutic results", British Journal of Haematology, 108, 505-510.
12. Kawa, K. (2003) "Diagnosis and treatment of Epstein-Barr virus - associated natural killer cell lymphoproliferative disease", Int. J. Hematol., 78, 24-31.
13. Kawa, K., Okamura, T., Yasui, M., Sato, E. and Inoue, M.. (2002) "Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease" , Crit. Rev. Oncol. Hematol., 44, 251-257.
14. Okamura, T., Hatsukawa, Y., Arai, H., Inoue, M. and Kawa, K. (2000) "Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation", Lancet, 356, 223-224.
15. Micallef, M.J., Tanimoto, T., Torigoe, K., Nishida, Y., Kohgo, K., Ikegami, H., et al. (1999) "Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity", Cancer Immunology Imunotherapy, 48, 109-117.
16. Ratcliffe, M,A., Roditi, G. and Adamson, D.J.A. (1992) "Interleukin-2 and splenic enlargement", Journal of the National Cancer Institute, 84, 810-811.
17. Janka, G.E. (1983) "Familial hemophagocytic lymphohistiocytosis" European Journal of Pediatrics, 140, 221-230.
18. Esumi, N., Ikushima, S., Hibi, S., Todo, S. and Imashuku, S. (1988) "High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome", Cancer, 61, 2071-2076.
19. Ohshima, K., Shimazaki, K. and Sugihara, M. (1999) "Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: Association with Epstein-Barr virus and apoptosis", Pathology International, 49, 533-540.